- Report
- October 2024
- 182 Pages
Global
From €3348EUR$3,545USD£2,848GBP
€3720EUR$3,939USD£3,164GBP
- Report
- April 2025
- 196 Pages
Global
From €5147EUR$5,450USD£4,378GBP
- Report
- April 2025
- 100 Pages
Global
From €4675EUR$4,950USD£3,976GBP
- Report
- March 2025
- 250 Pages
Global
From €4240EUR$4,490USD£3,607GBP
- Report
- July 2024
- 175 Pages
Global
From €4722EUR$5,000USD£4,016GBP
- Report
- May 2024
- 136 Pages
Global
From €6138EUR$6,499USD£5,220GBP
- Report
- May 2024
- 133 Pages
Global
From €6138EUR$6,499USD£5,220GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3541EUR$3,750USD£3,012GBP
- Report
- February 2025
- 186 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Report
- December 2023
- 130 Pages
Global
From €5619EUR$5,950USD£4,779GBP
- Report
- April 2021
China
From €2455EUR$2,600USD£2,088GBP
- Report
- November 2022
- 191 Pages
From €3258EUR$3,450USD£2,771GBP
- Report
- November 2022
- 210 Pages
Asia Pacific
From €3258EUR$3,450USD£2,771GBP
- Report
- November 2022
- 222 Pages
Europe
From €3258EUR$3,450USD£2,771GBP
- Report
- November 2022
- 197 Pages
Middle East, Africa
From €3258EUR$3,450USD£2,771GBP
- Report
- November 2022
- 193 Pages
North America
From €3258EUR$3,450USD£2,771GBP
- Report
- August 2022
- 330 Pages
Global
From €4203EUR$4,450USD£3,575GBP
- Report
- August 2022
- 117 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Drug Pipelines
- February 2024
- 80 Pages
Global
From €1889EUR$2,000USD£1,607GBP
- Report
- April 2023
- 147 Pages
Global
From €4674EUR$4,949USD£3,975GBP

Oseltamivir, also known as Tamiflu, is an antiviral medication used to treat and prevent influenza. It is a neuraminidase inhibitor, meaning it works by blocking the activity of the influenza virus in the body. Oseltamivir is used to treat both seasonal and pandemic influenza, and is the only antiviral drug approved by the US Food and Drug Administration for the treatment of influenza. It is also used to prevent influenza in people who have been exposed to the virus.
Oseltamivir is available in both oral and intravenous forms, and is typically prescribed for five days. Common side effects include nausea, vomiting, and diarrhea. It is important to note that oseltamivir is not effective against other types of infectious diseases.
The oseltamivir market is highly competitive, with several major pharmaceutical companies producing the drug. These include Roche, GlaxoSmithKline, Sanofi, and Mylan. Show Less Read more